Emma Savage (Moran)

Emma Savage (Moran) has extensive work experience in the pharmaceutical industry, starting as a Clinical Data Assistant at Zeneca Pharmaceuticals in 1996. Emma later worked as a Study Data Manager at Roche, a Team Leader at GSK, and WW Leader of CRF Design/Team Leader at PAREXEL. In 2003, they became a Study Delivery Leader at AstraZeneca, and from 2007 to 2010, they worked as a Clinical Trials Project Manager at PanGenetics BV. Emma served as a Consultant Clinical Project Manager-Oncology at TalentBank from 2010 to 2011. From 2011 to 2018, Emma worked at Roche as a Clinical Research Study Leader-Neuroscience and a Clinical Programme Leader-Neuroscience and Rare Diseases. Most recently, they worked at IQVIA from 2018 to 2023, where they held the roles of CNS Therapeutic Strategy Leader, Director, and Senior Director. Emma currently works as the VP of CNS at VIAL, where they started in June 2023.

Emma Savage (Moran) attended The Manchester Metropolitan University from 1992 to 1996. During this time, they earned a Bachelor of Science (BSc) with honors in Biology and Technology. No other education history is provided.